familial hyperlipidaemias
家族性高脂血症
combined hyperlipidaemias
混合型高脂血症
severe hyperlipidaemias
嚴重高脂血症
managing lipidaemias
高脂血症的管理
screening for lipidaemias
高脂血症篩查
treating lipidaemias
高脂血症的治療
lipidaemias patients
高脂血症患者
lipidaemias risk
高脂血症風險
lipidaemias levels
高脂血症水平
lipidaemias diagnosis
高脂血症診斷
lipidaemias are a group of disorders characterized by abnormal lipid levels in the bloodstream.
脂質血症是一組以血液中脂質水平異常為特徵的疾病。
regular screening for lipidaemias helps identify at-risk patients before serious complications develop.
定期篩查脂質血症有助於在嚴重併發症發生前識別高風險患者。
familial lipidaemias often require genetic counselling and long-term management strategies.
家族性脂質血症通常需要遺傳諮詢和長期管理策略。
secondary lipidaemias may resolve once the underlying condition is successfully treated.
繼發性脂質血症在基礎疾病成功治療後可能會得到解決。
managing mixed lipidaemias typically requires a combination of medication and lifestyle changes.
管理混合型脂質血症通常需要藥物治療和生活方式改變的組合。
severe lipidaemias increase the risk of premature cardiovascular disease significantly.
嚴重的脂質血症會顯著增加早發心血管疾病的風險。
doctors recommend routine testing for lipidaemias in patients with diabetes.
醫生建議對糖尿病患者進行脂質血症的常規檢查。
primary lipidaemias result from genetic mutations affecting lipid metabolism pathways.
原發性脂質血症是由影響脂質代謝途徑的基因突變引起的。
treatment goals for lipidaemias include lowering ldl cholesterol and raising hdl levels.
脂質血症的治療目標包括降低ldl膽固醇和提高hdl水平。
dietary modifications remain cornerstone therapy for mild to moderate lipidaemias.
飲食調整仍然是輕度至中度脂質血症的基石治療。
lipidaemias prevalence varies significantly across different ethnic populations worldwide.
脂質血症的患病率在全球不同族群中存在顯著差異。
early intervention for lipidaemias can prevent irreversible damage to blood vessels.
早期干預脂質血症可以預防血管不可逆的損傷。
statins are commonly prescribed medications for controlling various types of lipidaemias.
他汀類藥物是用於控制各種類型脂質血症的常見處方藥。
familial hyperlipidaemias
家族性高脂血症
combined hyperlipidaemias
混合型高脂血症
severe hyperlipidaemias
嚴重高脂血症
managing lipidaemias
高脂血症的管理
screening for lipidaemias
高脂血症篩查
treating lipidaemias
高脂血症的治療
lipidaemias patients
高脂血症患者
lipidaemias risk
高脂血症風險
lipidaemias levels
高脂血症水平
lipidaemias diagnosis
高脂血症診斷
lipidaemias are a group of disorders characterized by abnormal lipid levels in the bloodstream.
脂質血症是一組以血液中脂質水平異常為特徵的疾病。
regular screening for lipidaemias helps identify at-risk patients before serious complications develop.
定期篩查脂質血症有助於在嚴重併發症發生前識別高風險患者。
familial lipidaemias often require genetic counselling and long-term management strategies.
家族性脂質血症通常需要遺傳諮詢和長期管理策略。
secondary lipidaemias may resolve once the underlying condition is successfully treated.
繼發性脂質血症在基礎疾病成功治療後可能會得到解決。
managing mixed lipidaemias typically requires a combination of medication and lifestyle changes.
管理混合型脂質血症通常需要藥物治療和生活方式改變的組合。
severe lipidaemias increase the risk of premature cardiovascular disease significantly.
嚴重的脂質血症會顯著增加早發心血管疾病的風險。
doctors recommend routine testing for lipidaemias in patients with diabetes.
醫生建議對糖尿病患者進行脂質血症的常規檢查。
primary lipidaemias result from genetic mutations affecting lipid metabolism pathways.
原發性脂質血症是由影響脂質代謝途徑的基因突變引起的。
treatment goals for lipidaemias include lowering ldl cholesterol and raising hdl levels.
脂質血症的治療目標包括降低ldl膽固醇和提高hdl水平。
dietary modifications remain cornerstone therapy for mild to moderate lipidaemias.
飲食調整仍然是輕度至中度脂質血症的基石治療。
lipidaemias prevalence varies significantly across different ethnic populations worldwide.
脂質血症的患病率在全球不同族群中存在顯著差異。
early intervention for lipidaemias can prevent irreversible damage to blood vessels.
早期干預脂質血症可以預防血管不可逆的損傷。
statins are commonly prescribed medications for controlling various types of lipidaemias.
他汀類藥物是用於控制各種類型脂質血症的常見處方藥。
探索常見搜尋詞彙